22q11 Deletion Syndrome Clinical Trials

10 clinical trials for 22q11 Deletion Syndrome across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders — RECRUITING · PHASE2
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ORALLY ADMINISTERED NNZ-2591 COMPARED WITH PLACEBO IN PEDIATRIC PARTICIPANTS WITH PHELAN MCDERMID SYNDROME — RECRUITING · PHASE3
• Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome — RECRUITING · NA
• A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGOZAFERMIN IN SUBJECTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) AND FIBROSIS — RECRUITING · PHASE3
• GROWing Up With Rare GENEtic Syndromes — RECRUITING
• Mindfulness Program for Adolescents With 22q11DS — COMPLETED · NA
• NB-001 in Children and Adolescents With 22q11 Deletion Syndrome — COMPLETED · PHASE2
• A RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO ASSESS THE SAFETY AND EFFICACY OF NB-001 IN CHILDREN AND ADOLESCENTS WITH 22Q11 DELETION SYNDROME — COMPLETED
• SNP-based Microdeletion and Aneuploidy RegisTry (SMART) — COMPLETED
• Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. — OTHER · PHASE2

Refine this search